<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>SODIUM CHLORIDE- sodium chloride injection, solution </strong><br>Baxter Healthcare Corporation<br></p></div>
<h1>Sodium Chloride Injection, USP<br>in VIAFLEX Plastic Container</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_de1b680b-e132-4e4e-b0cd-1434c33e5021"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents. The nominal pH is 5.0 (4.5 to 7.0). Composition, osmolarity, and ionic concentration are shown below:</p>
<p><span class="Bold">0.45% Sodium Chloride Injection, USP</span> contains 4.5 g/L Sodium Chloride, USP (NaCl) and is hypotonic with an osmolarity of 154 mOsmol/L (calc). It contains 77 mEq/L sodium and 77 mEq/L chloride.</p>
<p><span class="Bold">0.9% Sodium Chloride Injection, USP</span> contains 9 g/L Sodium Chloride, USP (NaCl) with an osmolarity of 308 mOsmol/L (calc). It contains 154 mEq/L sodium and 154 mEq/L chloride.</p>
<p>The VIAFLEX plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_222aadc9-5dc9-4b34-9228-31ffaa563090"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Sodium Chloride Injection, USP has value as a source of water and electrolytes. It is capable of inducing <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span> depending on the clinical condition of the patient.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_bde19139-33dd-4106-a609-eaeb101fb460"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Sodium Chloride Injection, USP is indicated as a source of water and electrolytes.</p>
<p>0.9% Sodium Chloride Injection, USP is also indicated for use as a priming solution in hemodialysis procedures.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_c4d3cf1f-65ea-40aa-b6b7-27cdc73cab17"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">None known.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_d4d5806d-69b0-43c1-983a-c8295850311b"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span>/infusion reactions, including <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">pyrexia</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">chills</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, and <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span> have been reported with 0.9% Sodium Chloride Injection, USP and may occur with 0.45% Sodium Chloride Injection, USP. </p>
<p>Stop the infusion immediately if signs or symptoms of a <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reaction</span> develop, such as <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">chest pain</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span> and <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>. Appropriate therapeutic countermeasures must be instituted as clinically indicated.  </p>
<p>Depending on the volume and rate of infusion, the intravenous administration of Sodium Chloride Injection, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, <span class="product-label-link" type="condition" conceptid="4266976" conceptname="Overhydration">overhydration</span>/<span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">hypervolemia</span>, congested states, <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span>, or acid-base imbalance.  The risk of dilutive states is inversely proportional to the electrolyte concentration of the injection. The risk of solute overload causing congested states with peripheral and <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span> is directly proportional to the electrolyte concentrations of the injection.</p>
<p>Monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient or the rate of administration warrants such evaluation.</p>
<p>Administer 0.9% Sodium Chloride Injection, USP with particular caution, to patients with or at risk for <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">hypernatremia</span>, <span class="product-label-link" type="condition" conceptid="4253927" conceptname="Hyperchloremia">hyperchloremia</span>, or <span class="product-label-link" type="condition" conceptid="4245042" conceptname="Metabolic acidosis">metabolic acidosis</span>.</p>
<p>The infusion of solutions with 0.45% Sodium Chloride Injection, USP may result in <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>. Close clinical monitoring may be warranted. <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">Hyponatremia</span> can lead to <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>, <span class="product-label-link" type="condition" conceptid="4061577" conceptname="Lethargy">lethargy</span>, <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>, <span class="product-label-link" type="condition" conceptid="376690" conceptname="Cerebral edema">cerebral edema</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>. The risk for <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span> is increased, for example, in children, elderly, women, postoperatively, in persons with <span class="product-label-link" type="condition" conceptid="4049477" conceptname="Psychogenic polydipsia">psychogenic polydipsia</span>, and in patients treated with medications that increase the risk of <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span> (such as certain antiepileptic and psychotropic medications). The risk for developing <span class="product-label-link" type="condition" conceptid="4047765" conceptname="Hyponatremic encephalopathy">hyponatremic encephalopathy</span> is increased, for example, in pediatric patients (≤16 years of age), women (in particular pre-menopausal women), in patients with <span class="product-label-link" type="condition" conceptid="437390" conceptname="Hypoxemia">hypoxemia</span>, and in patients with underlying central nervous system disease. Acute symptomatic <span class="product-label-link" type="condition" conceptid="4047765" conceptname="Hyponatremic encephalopathy">hyponatremic encephalopathy</span> is considered a medical emergency.</p>
<p>Administer Sodium Chloride Injection, USP with particular caution, to patients with or at risk for <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">hypervolemia</span> or with conditions that may cause <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">sodium retention</span>, <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">fluid overload</span> and <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>; such as patients with <span class="product-label-link" type="condition" conceptid="434000" conceptname="Primary aldosteronism">primary hyperaldosteronism</span>, or secondary hyperaldosteronism [e.g., associated with <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, liver disease (including cirrhosis), <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span> (including <span class="product-label-link" type="condition" conceptid="4118795" conceptname="Renal artery stenosis">renal artery stenosis</span>, <span class="product-label-link" type="condition" conceptid="4140207" conceptname="Nephrosclerosis">nephrosclerosis</span>) or pre-<span class="product-label-link" type="condition" conceptid="443700" conceptname="Eclampsia">eclampsia</span>]. Certain medications may increase risk of sodium and <span class="product-label-link" type="condition" conceptid="4125002" conceptname="Idiopathic fluid retention">fluid retention</span>, see <a href="#ID_37927098-eaa0-482b-8bf8-70606cc135f4">Drug Interactions</a>.</p>
<p>Administer Sodium Chloride Injection, USP with particular caution, to patients with severe <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span>. In such patients, administration of Sodium Chloride Injection, USP may result in <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">sodium retention</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_035f7cfa-047e-47d0-bb79-7f389c7a4432"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="ID_9ea0bfa9-a82f-44c3-a778-f28fd3388486"></a><a name="section-6.1"></a><p></p>
<h2>General  </h2>
<p class="First">Do not connect flexible plastic containers in series in order to avoid <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">air embolism</span> due to possible residual air contained in the primary container.  Such use could result in <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">air embolism</span> due to residual air being drawn from the primary container before administration of the fluid from the secondary container is completed. </p>
<p>Pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">air embolism</span> if the residual air in the container is not fully evacuated prior to administration. </p>
<p>Use of a vented intravenous administration set with the vent in the open position could result in <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">air embolism</span>. Vented intravenous administration sets with the vent in the open position should not be used with flexible plastic containers. </p>
<p>Do not mix or administer 0.45% Sodium Chloride Injection, USP through the same administration set with whole blood or cellular blood components.</p>
<p>Rapid correction of hypo- and <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">hypernatremia</span> is potentially dangerous (risk of serious neurologic complications). Dosage, rate, and duration of administration should be determined by a physician experienced in intravenous fluid therapy.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="ID_37927098-eaa0-482b-8bf8-70606cc135f4"></a><a name="section-6.2"></a><p></p>
<h2>Drug Interactions </h2>
<p class="First">Caution must be exercised in the administration of Sodium Chloride Injection, USP to patients treated with drugs that may increase the risk of sodium and <span class="product-label-link" type="condition" conceptid="4125002" conceptname="Idiopathic fluid retention">fluid retention</span>, such as corticosteroids. </p>
<p>Caution is advised in patients treated with lithium. Renal sodium and lithium clearance may be decreased in the presence of <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>. Administration of 0.45% Sodium Chloride Injection, USP may result in increased lithium levels. </p>
<p>Renal sodium and lithium clearance may be increased during administration of 0.9% Sodium Chloride Injection, USP. Administration of 0.9% Sodium Chloride Injection, USP, may result in decreased lithium levels.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_825fa351-62e3-4eca-9fcf-789c3e006633"></a><a name="section-6.3"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_1fc195aa-2382-498f-90b2-597ac8eaee77"></a><a name="section-6.3.1"></a><p></p>
<h3>Pregnancy Category C</h3>
<p class="First">There are no adequate and well controlled studies with Sodium Chloride Injection, USP in pregnant women and animal reproduction studies have not been conducted with this drug.  Therefore, it is not known whether Sodium Chloride Injection, USP can cause fetal harm when administered to a pregnant woman.  Sodium Chloride Injection, USP should be given to a during pregnancy only if the potential benefit justifies the potential risk to the fetus.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_bf3823d4-d307-4d59-8da6-a945c5e58fe2"></a><a name="section-6.4"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is present in human milk. Because many drugs are present in human milk, caution should be exercised when Sodium Chloride Injection, USP is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_8ce3c966-33c4-4494-89f5-c0dd44b78642"></a><a name="section-6.5"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">The use of Sodium Chloride Injection, USP in pediatric patients is based on clinical practice. (See <a href="#i4i_dosage_admin_id_821736b8-1c4e-4ab7-9fa8-06dddf6d5da1">DOSAGE AND ADMINISTRATION</a>).</p>
<p>Plasma electrolyte concentrations should be closely monitored in the pediatric population as this population may have impaired ability to regulate fluids and electrolytes.</p>
<p>The infusion of hypotonic fluids (0.45% Sodium Chloride Injection, USP) together with the non-osmotic secretion of ADH may result in <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span> in patients with acute <span class="product-label-link" type="condition" conceptid="436375" conceptname="Hypovolemia">volume depletion</span>. <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">Hyponatremia</span> can lead to <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>, <span class="product-label-link" type="condition" conceptid="4061577" conceptname="Lethargy">lethargy</span>, <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>, <span class="product-label-link" type="condition" conceptid="376690" conceptname="Cerebral edema">cerebral edema</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>, therefore acute symptomatic <span class="product-label-link" type="condition" conceptid="4047765" conceptname="Hyponatremic encephalopathy">hyponatremic encephalopathy</span> is considered a medical emergency.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="i4i_geriatric_use_id_7de43bbb-357e-47f9-a5b8-75e592a6b7e4"></a><a name="section-6.6"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Clinical studies of Sodium Chloride Injection, USP did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. </p>
<p>This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_345e2c15-c64d-4b0b-977f-2845a6c62358"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_10681a24-4b1e-48de-b56a-c89d8f1a6fd6"></a><a name="section-7.1"></a><p></p>
<h2>Post-Marketing Adverse Reactions </h2>
<p class="First">The following adverse reactions have been identified during postapproval use of Sodium Chloride Injection, USP.  Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.  </p>
<p>The following adverse reactions have been reported in the post-marketing experience during use of 0.9% Sodium Chloride Injection, USP and include the following:</p>
<p><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>/infusion reactions, including <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">pyrexia</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">chills</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, and <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>.</p>
<p>Also reported are infusion site reactions, such as infusion site <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, injection site streaking, <span class="product-label-link" type="condition" conceptid="4235891" conceptname="Burning sensation">burning sensation</span>, and infusion site <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>.</p>
<p>The following adverse reactions have not been reported with 0.9% Sodium Chloride Injection, USP but may occur: <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">hypernatremia</span>, hyperchloremic <span class="product-label-link" type="condition" conceptid="4245042" conceptname="Metabolic acidosis">metabolic acidosis</span>, and <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>, which may be symptomatic.  </p>
<p><span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">Hyponatremia</span> has been reported for 0.45% Sodium Chloride Injection, USP (see <a href="#i4i_pediatric_use_id_8ce3c966-33c4-4494-89f5-c0dd44b78642">Pediatric Use</a> section).</p>
<p>The following adverse reactions have not been reported with 0.45% Sodium Chloride Injection, USP but may occur: hyperchloremic <span class="product-label-link" type="condition" conceptid="4245042" conceptname="Metabolic acidosis">metabolic acidosis</span>, <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>/infusion reactions (including <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">pyrexia</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">chills</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, and <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>), and infusion site reactions (such as infusion site <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, injection site streaking, <span class="product-label-link" type="condition" conceptid="4235891" conceptname="Burning sensation">burning sensation</span>, infusion site <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>).</p>
<p>If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.</p>
</div>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="ID_1fae3415-2598-4f4e-8da5-1f0b2f64017c"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE </h1>
<p class="First">Excessive administration of 0.45% Sodium Chloride Injection, USP may lead to hypo- and <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">hypernatremia</span>, while excessive administration of 0.9% Sodium Chloride Injection, USP may lead to <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">hypernatremia</span>. Both hypo- and <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">hypernatremia</span> can lead to CNS manifestations, including <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>, <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>, <span class="product-label-link" type="condition" conceptid="376690" conceptname="Cerebral edema">cerebral edema</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>.</p>
<p>Excessive administration of Sodium Chloride Injection, USP may lead to sodium overload (which can lead to central and/or <span class="product-label-link" type="condition" conceptid="4094513" conceptname="Ankle edema">peripheral edema</span>).</p>
<p>When assessing an <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, any additives in the solution must also be considered. The effects of an <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> may require immediate medical attention and treatment.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_821736b8-1c4e-4ab7-9fa8-06dddf6d5da1"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">All injections in VIAFLEX plastic containers are intended for intravenous administration using sterile and nonpyrogenic equipment. </p>
<p>As directed by a physician. Dosage, rate, and duration of administration are to be individualized and depend upon the indication for use, the patient’s age, weight, clinical condition, concomitant treatment, and on the patient’s clinical and laboratory response to treatment.  </p>
<p>When other electrolytes or medicines are added to this solution, the dosage and the infusion rate will also be dictated by the dose regimen of the additions.</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Use of a final filter is recommended during administration of all parenteral solutions, where possible.</p>
<p>Do not administer unless the solution is clear and seal is intact. </p>
<p>Additives may be incompatible with Sodium Chloride Injection, USP. As with all parenteral solutions, compatibility of the additives with the solution must be assessed before addition. Before adding a substance or medication, verify that it is soluble and/or stable in water and that the pH range of Sodium Chloride Injection, USP is appropriate. After addition, check for unexpected color changes and/or the appearance of precipitates, insoluble complexes or crystals.</p>
<p>The instructions for use of the medication to be added and other relevant literature must be consulted. Additives known or determined to be incompatible must not be used. When introducing additives to Sodium Chloride Injection, USP, aseptic technique must be used. Mix the solution thoroughly when additives have been introduced. Do not store solutions containing additives. </p>
<p>After opening the container, the contents should be used immediately and should not be stored for a subsequent infusion. Do not reconnect any partially used containers. Discard any unused portion.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_3f4033ab-0103-47eb-b528-717989fda532"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">The available sizes of each injection in VIAFLEX plastic containers are shown below:</p>
<table width="100%">
<col width="21%">
<col width="23%">
<col width="23%">
<col width="33%">
<tbody class="Headless">
<tr class="First">
<td class="Toprule"><p class="First"><span class="Bold">Code</span></p></td>
<td class="Toprule"><p class="First"><span class="Bold">Size (mL)</span></p></td>
<td class="Toprule"><p class="First"><span class="Bold">NDC</span></p></td>
<td class="Toprule"><p class="First"><span class="Bold">Product Name</span></p></td>
</tr>
<tr>
<td><p class="First">2B1313</p></td>
<td><p class="First">500</p></td>
<td><p class="First">0338-0043-03</p></td>
<td><p class="First">0.45% Sodium Chloride Injection, USP</p></td>
</tr>
<tr>
<td><p class="First">2B1314</p></td>
<td><p class="First">1000</p></td>
<td><p class="First">0338-0043-04</p></td>
<td></td>
</tr>
<tr>
<td><p class="First">2B1300</p></td>
<td><p class="First">25 Quad Pack</p></td>
<td><p class="First">0338-0049-10</p></td>
<td><p class="First">0.9% Sodium Chloride Injection, USP</p></td>
</tr>
<tr>
<td></td>
<td><p class="First">50</p></td>
<td></td>
<td></td>
</tr>
<tr>
<td><p class="First">2B1306</p></td>
<td><p class="First">Single pack</p></td>
<td><p class="First">0338-0049-41</p></td>
<td></td>
</tr>
<tr>
<td><p class="First">2B1301</p></td>
<td><p class="First">Quad pack</p></td>
<td><p class="First">0338-0049-11</p></td>
<td></td>
</tr>
<tr>
<td><p class="First">2B1308</p></td>
<td><p class="First">Multi pack</p></td>
<td><p class="First">0338-0049-31</p></td>
<td></td>
</tr>
<tr>
<td></td>
<td><p class="First">100</p></td>
<td></td>
<td></td>
</tr>
<tr>
<td><p class="First">2B1307</p></td>
<td><p class="First">Single pack</p></td>
<td><p class="First">0338-0049-48</p></td>
<td></td>
</tr>
<tr>
<td><p class="First">2B1302</p></td>
<td><p class="First">Quad pack</p></td>
<td><p class="First">0338-0049-18</p></td>
<td></td>
</tr>
<tr>
<td><p class="First">2B1309</p></td>
<td><p class="First">Multi pack</p></td>
<td><p class="First">0338-0049-38</p></td>
<td></td>
</tr>
<tr>
<td><p class="First">2B1321</p></td>
<td><p class="First">150</p></td>
<td><p class="First">0338-0049-01</p></td>
<td></td>
</tr>
<tr>
<td><p class="First">2B1322</p></td>
<td><p class="First">250</p></td>
<td><p class="First">0338-0049-02</p></td>
<td></td>
</tr>
<tr>
<td><p class="First">2B1323</p></td>
<td><p class="First">500</p></td>
<td><p class="First">0338-0049-03</p></td>
<td></td>
</tr>
<tr class="Last">
<td class="Botrule"><p class="First">2B1324</p></td>
<td class="Botrule"><p class="First">1000</p></td>
<td class="Botrule"><p class="First">0338-0049-04</p></td>
<td class="Botrule"></td>
</tr>
</tbody>
</table>
<p>Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C/77°F); brief exposure up to 40°C/104°F does not adversely affect the product.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_104e6af0-1a42-4177-8325-f2662fddf49f"></a><a name="section-11"></a><p></p>
<h1>DIRECTIONS FOR USE OF VIAFLEX PLASTIC CONTAINER</h1>
<p class="First">For Information on Risk of <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">Air Embolism</span> – see <a href="#i4i_precautions_id_035f7cfa-047e-47d0-bb79-7f389c7a4432">PRECAUTIONS</a>.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_4fc0e30f-a902-4c9e-b1b6-f2b3bc90c5fa"></a><a name="section-11.1"></a><p></p>
<h2>To Open</h2>
<p class="First">Tear overwrap down side at slit and remove solution container. Visually inspect the container. If the outlet port protector is damaged, <span class="product-label-link" type="condition" conceptid="4071366" conceptname="Indifference">detached</span>, or not present, discard container as solution path <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">sterility</span> may be impaired. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">sterility</span> may be impaired. If supplemental medication is desired, follow directions below.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_4b7f4bb4-bad6-4253-a43a-72752392ab01"></a><a name="section-11.2"></a><p></p>
<h2>Preparation for Administration</h2>
<dl>
<dt>1.</dt>
<dd>Suspend container from eyelet support.</dd>
<dt>2.</dt>
<dd>Remove protector from outlet port at bottom of container.</dd>
<dt>3.</dt>
<dd>Attach administration set. Refer to complete directions accompanying set.</dd>
</dl>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_0acdfdb8-f90f-4c99-80b9-ed4775224290"></a><a name="section-11.3"></a><p></p>
<h2>To Add Medication</h2>
<p class="First">Additives may be incompatible</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_f2282cd8-5f56-49cc-93d0-6b4d2a3851bd"></a><a name="section-11.4"></a><p></p>
<h2>To add medication before solution administration</h2>
<dl>
<dt>1.</dt>
<dd>Prepare medication site.</dd>
<dt>2.</dt>
<dd>Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.</dd>
<dt>3.</dt>
<dd>Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.</dd>
</dl>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_aa39c24c-92d0-4bde-bcbf-776707635469"></a><a name="section-11.5"></a><p></p>
<h2>To add medication during solution administration</h2>
<dl>
<dt>1.</dt>
<dd>Close clamp on the set.</dd>
<dt>2.</dt>
<dd>Prepare medication site.</dd>
<dt>3.</dt>
<dd>Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.</dd>
<dt>4.</dt>
<dd>Remove container from IV pole and/or turn to an upright position.</dd>
<dt>5.</dt>
<dd>Evacuate both ports by squeezing them while container is in the upright position.</dd>
<dt>6.</dt>
<dd>Mix solution and medication thoroughly.</dd>
<dt>7.</dt>
<dd>Return container to in-use position and continue administration.</dd>
</dl>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_ad276a62-4bdc-49c9-bbfb-e9101430c08b"></a><a name="section-12"></a><p></p>
<p class="First"><span class="Bold">Baxter Healthcare Corporation</span><br>Deerfield, IL 60015 USA <br>Printed in USA</p>
<p>Distributed in Canada by<br>Baxter Corporation<br>Mississauga, ON L5N 0C2</p>
<p><span class="Bold">07-19-71-904</span></p>
<p><span class="Bold">Rev. December 2014</span></p>
<p>Baxter, PL 146, and Viaflex are trademarks of Baxter International Inc.</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_224b17d2-0bb4-4420-b8b9-e1c16f1da078"></a><a name="section-13"></a><p></p>
<h1>PACKAGE LABELING - PRINCIPAL DISPLAY PANEL</h1>
<div class="Figure">
<a name="id234514553"></a><img alt="Representative Container Label 0338-0049-18" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f55bd888-5e01-474d-871b-24654c070178&amp;name=image-01.jpg">
</div>
<p class="First">LOT<br>EXP</p>
<p>2B1302<br>NDC 0338-0049-18</p>
<p><span class="Bold">0.9% Sodium Chloride Injection USP</span></p>
<p><span class="Bold">100 mL</span></p>
<p>Single dose container <br>Each 100 mL contains <br>900 mg Sodium Chloride USP <br>pH 5.0 (4.5 to 7.0) mEq/100 mL <br>Sodium 15 Chloride 15 Osmolarity <br>308 mOsmol/L (calc) Sterile <br>Nonpyrogenic Read package insert <br>for full information Additives may <br>be incompatible Dosage <br>Intravenously as directed by a<br>physician Cautions Must not be used <br>in series connections Do not use <br>unless solution is clear <span class="Bold">Rx Only</span><br>VIAFLEX container<br>PL 146<br>Baxter VIAFLEX and PL 146 are trademarks of<br>Baxter International Inc</p>
<p><span class="Bold"><span class="Italics">Baxter</span></span><br><span class="Bold">Baxter Healthcare Corporation</span><br>Deerfiled IL 60015 USA<br>Made in USA</p>
<div class="Figure">
<a name="id1157495284"></a><img alt="Sodium Chloride Injection Representative Carton Label  0338-049-18" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f55bd888-5e01-474d-871b-24654c070178&amp;name=image-02.jpg">
</div>
<p><span class="Bold">Lot: PXX</span><br><span class="Bold">QTY:</span> 96-100 mL</p>
<p><span class="Bold">Exp: XX XX</span><br><span class="Bold">Code:  2B1302</span><br><span class="Bold">NDC: 0338-0049-18</span></p>
<p><span class="Bold">0.9% SODIUM CHLORIDE INJ USP</span></p>
<p>(17) XXXX00 (10) PXX</p>
<p>(01) 50303380049184</p>
<div class="Figure">
<a name="id2102130325"></a><img alt="Sodium Chloride Representative Container Label  0338-043-03" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f55bd888-5e01-474d-871b-24654c070178&amp;name=image-03.jpg">
</div>
<p>LOT     EXP</p>
<p><span class="Bold">281313</span></p>
<p>NDC0338-0043-03</p>
<p><span class="Bold">0.45</span>°/<span class="Bold">o Sodium Chloride</span><br><span class="Bold">Injection USP</span></p>
<p><span class="Bold">500ml</span></p>
<p>EACH 100 mL CONTAINS      450 rng SODIUM CHLORIDE USP<br>pH 5.0 (4. 5 TO 7.0)    mEq/L  SODIUM 77     CHLORIDE  77<br>HYPOTONIC    OSMOLARITY  154 mQsmol/L (CALC)     STERILE <br>NONPYROGENIC    SINGLE DOSE CONTAINER    ADDITIVES MAY BE INCOMPATIBLE     CONSULT   WITH PHARMACIST  IF  AVAILABLE<br>WHEN INTRODUCING ADDITIVES USE ASEPTIC TECHNIQUE    MIX <br>THOROUGHLY     DO NOT  STORE   DOSAGE  INTRAVENOUSLY AS <br>DIRECTED BY  A PHYSICIAN     SEE  DIRECTIONS     CAUTIONS<br>SQUEEZE AND INSPECT INNER BAG WHICH MAINTAINS PRODUCT <br><span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">STERILITY</span>  DISCARD IF LEAKS ARE FOUND    MUST NOT BE USED <br>IN SERIES CONNECTIONS    Do NOT USE UNLESS SOLUTION IS <br>CLEAR      Rx  ONLY     STORE UNIT  IN  MOISTURE  BARRIER <br>OVERWRAP AT ROOM TEMPERATURE (25°C/77°F) UNTIL READY <br>TO USE   AVOID EXCESSIVE HEAT   SEE INSERT</p>
<p>VIAFLEX CONTAINER    Pl  146 PLASTIC</p>
<p>BAXTER  VIAFLEX AND PL 146 ARE TRADEMARKS OF <br>BAXTER INTERNATIONAL INC</p>
<p>FOR PRODUCT  INFORMATION  1-800-933-0303</p>
<p><span class="Bold"><span class="Italics">Baxter Logo</span></span></p>
<p>BAXTER HEALTHCARE CORPORATION<br>DEERFIELD IL 60015 USA</p>
<p>MADE IN USA</p>
<p>07-25-34-139</p>
<div class="Figure">
<a name="id481587649"></a><img alt="Sodium Chloride Representative Carton Label  0338-0043-03" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f55bd888-5e01-474d-871b-24654c070178&amp;name=image-04.jpg">
</div>
<p>2B1313Q               24-500 ML</p>
<p>VIAFLEX®  CONTAINER</p>
<p>0.45% SODIUM CHLORIDE <br>INJECTION, USP</p>
<p>EXP</p>
<p>XXXXX</p>
<p>SECONDARY BAR CODE</p>
<p>(17) YYMMOO (10) XXXXX</p>
<p>LOT</p>
<p>XXXXX</p>
<p>PRIMARY BAR CODE</p>
<p>(01) 50303380043038</p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>SODIUM CHLORIDE 		
					</strong><br><span class="contentTableReg">sodium chloride injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0338-0049</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM CHLORIDE</strong> (SODIUM CATION and CHLORIDE ION) </td>
<td class="formItem">SODIUM CHLORIDE</td>
<td class="formItem">9 g  in 1000 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0338-0049-01</td>
<td class="formItem">150 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0338-0049-02</td>
<td class="formItem">250 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:0338-0049-03</td>
<td class="formItem">500 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">4</th>
<td class="formItem">NDC:0338-0049-04</td>
<td class="formItem">1000 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">5</th>
<td class="formItem">NDC:0338-0049-10</td>
<td class="formItem">4  in 1 PACKAGE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">5</th>
<td class="formItem"></td>
<td class="formItem">25 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">6</th>
<td class="formItem">NDC:0338-0049-41</td>
<td class="formItem">1  in 1 PACKAGE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">6</th>
<td class="formItem"></td>
<td class="formItem">50 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">7</th>
<td class="formItem">NDC:0338-0049-11</td>
<td class="formItem">4  in 1 PACKAGE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">7</th>
<td class="formItem"></td>
<td class="formItem">50 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">8</th>
<td class="formItem">NDC:0338-0049-31</td>
<td class="formItem">16  in 1 PACKAGE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">8</th>
<td class="formItem"></td>
<td class="formItem">50 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">9</th>
<td class="formItem">NDC:0338-0049-48</td>
<td class="formItem">1  in 1 PACKAGE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">9</th>
<td class="formItem"></td>
<td class="formItem">100 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">10</th>
<td class="formItem">NDC:0338-0049-18</td>
<td class="formItem">4  in 1 PACKAGE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">10</th>
<td class="formItem"></td>
<td class="formItem">100 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">11</th>
<td class="formItem">NDC:0338-0049-38</td>
<td class="formItem">16  in 1 PACKAGE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">11</th>
<td class="formItem"></td>
<td class="formItem">100 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA016677</td>
<td class="formItem">12/09/1970</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>SODIUM CHLORIDE 		
					</strong><br><span class="contentTableReg">sodium chloride injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0338-0043</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM CHLORIDE</strong> (SODIUM CATION and CHLORIDE ION) </td>
<td class="formItem">SODIUM CHLORIDE</td>
<td class="formItem">4.5 g  in 1000 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0338-0043-03</td>
<td class="formItem">500 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0338-0043-04</td>
<td class="formItem">1000 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA018016</td>
<td class="formItem">02/02/1979</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>SODIUM CHLORIDE 		
					</strong><br><span class="contentTableReg">sodium chloride injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0338-1452</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM CHLORIDE</strong> (SODIUM CATION and CHLORIDE ION) </td>
<td class="formItem">SODIUM CHLORIDE</td>
<td class="formItem">5 g  in 1000 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0338-1452-48</td>
<td class="formItem">100 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem">02/02/1979</td>
<td class="formItem">12/01/2014</td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0338-1452-02</td>
<td class="formItem">250 mL in 1 BAG; Combination Product Type = C112160</td>
<td class="formItem">02/02/1979</td>
<td class="formItem">01/01/2015</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA018016</td>
<td class="formItem">02/02/1979</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Baxter Healthcare Corporation
							(005083209)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Baxter Healthcare Corporation</td>
<td class="formItem"></td>
<td class="formItem">059140764</td>
<td class="formItem">ANALYSIS(0338-0043, 0338-1452), LABEL(0338-0043, 0338-1452), MANUFACTURE(0338-0043, 0338-1452), PACK(0338-0043, 0338-1452), STERILIZE(0338-0043, 0338-1452)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Baxter Healthcare Corporation</td>
<td class="formItem"></td>
<td class="formItem">189326168</td>
<td class="formItem">ANALYSIS(0338-0049), LABEL(0338-0049), MANUFACTURE(0338-0049), PACK(0338-0049), STERILIZE(0338-0049)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Baxter Healthcare Corporation</td>
<td class="formItem"></td>
<td class="formItem">194684502</td>
<td class="formItem">ANALYSIS(0338-0049, 0338-0043, 0338-1452)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 12/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>0ed452c5-f1c3-401c-b421-6e668ffa13c3</div>
<div>Set id: f55bd888-5e01-474d-871b-24654c070178</div>
<div>Version: 6</div>
<div>Effective Time: 20141222</div>
</div>
</div> <div class="DistributorName">Baxter Healthcare Corporation</div></p>
</body></html>
